Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for proteinuria in kidney transplant recipients
IRCT20230516058205N1Phase 4Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of spironolactone in proteinuria (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Proteinuria. Started Jun 2023; status: completed.
02
Drugs
spironolactone
03
Conditions
proteinuria
Beyond the preview
Go deeper on IRCT20230516058205N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230516058205N1.